AERPIO THERAPEUTICS, INC.

Profile

Company Names

AERPIO THERAPEUTICS, INC.

Addresses

9987 CARVER ROAD, SUITE 420, CINCINNATI, OH 45242

Phone Numbers

(513) 985-1920

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2011

State Incorporated:

DELAWARE

Total Amount Raised:

$62,005,672.00

Number of Funding Rounds:

5
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
5
2016-10-31 
$3,469,141.00 
$4,600,000.00 
$1,130,859.00 
Debt 
4
2016-03-31 
$4,536,531.00 
$9,200,000.00 
$4,663,469.00 
Debt 
3
2014-04-22 
$22,000,000.00 
$22,000,000.00 
$0.00 
Equity 
2
2012-08-28 
$27,000,000.00 
$31,011,902.00 
$4,011,902.00 
Equity 
1
2011-12-22 
$5,000,000.00 
$5,000,000.00 
$0.00 
Equity, Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
REINHARD 
 
AMBROS 
DIRECTOR
MICROCHIPS, INC.   |  TOKAI PHARMACEUTICALS INC   |  AERPIO THERAPEUTICS, INC.
ANUPAM 
 
DALAL 
DIRECTOR
AKEBIA THERAPEUTICS, INC.   |  AERPIO THERAPEUTICS, INC.   |  NORA THERAPEUTICS, INC.   |  AERPIO PHARMACEUTICALS, INC.   |  ACUTA OPPORTUNITY FUND, LP   |  ACUTA CAPITAL FUND, LP   |  ACUTA OPPORTUNITY OFFSHORE FUND, LTD.   |  ACUTA CAPITAL OFFSHORE FUND, LTD.   |  AADI BIOSCIENCE, INC.
WILLIAM 
 
DALY 
EXECUTIVE OFFICER
AERPIO THERAPEUTICS, INC.   |  BLACKROCK US CORE PROPERTY FUND, L.P.   |  MEISSA VACCINES INC
ALAN 
 
FISHMAN 
EXECUTIVE OFFICER
BEECH STREET CAPITAL, LLC   |  COPPER MOUNTAIN BEVERAGES, LLC   |  BARFIELD LMG, LLC   |  MD SOLARSCIENCES CORP.   |  AERPIO THERAPEUTICS, INC.   |  REGENT EDUCATION, INC   |  INTERACTIVE FRONTIERS INC
JOSEPH 
H. 
GARDNER 
EXECUTIVE OFFICER, DIRECTOR
AERPIO THERAPEUTICS, INC.
ADRIENNE 
 
GRAVES 
DIRECTOR
OCCULOGIX, INC.   |  AERPIO THERAPEUTICS, INC.   |  ENCORE VISION, INC.   |  TEARLAB CORP   |  ENVISIA THERAPEUTICS, INC.   |  SURFACE PHARMACEUTICALS, INC.   |  GREENBROOK TMS INC.   |  THEROPTIX, INC.   |  SURFACE OPHTHALMICS, INC.   |  OPUS GENETICS INC.   |  JELLISEE OPHTHALMICS INC.   |  QLARIS BIO, INC.
IAN 
A.W. 
HOWES 
EXECUTIVE OFFICER
AERPIO THERAPEUTICS, INC.   |  APOGEN BIOTECHNOLOGIES, INC.
CHAU 
 
KHUONG 
DIRECTOR
CERAPEDICS INC   |  AERPIO THERAPEUTICS, INC.   |  INSPIRE MEDICAL SYSTEMS, INC.   |  PIERIS PHARMACEUTICALS, INC.   |  SYNLOGIC, LLC   |  AERPIO PHARMACEUTICALS, INC.   |  SYNLOGIC, INC.   |  SYNLOGIC, INC.   |  PERFUSE THERAPEUTICS, INC.   |  GRAYBUG VISION, INC.   |  NOCTRIX HEALTH, INC.   |  GENNAO BIO, INC.   |  RESTORA MEDICAL, INC.
CAMPBELL 
 
MURRAY 
DIRECTOR
ALIOS BIOPHARMA INC   |  TOKAI PHARMACEUTICALS INC   |  AILERON THERAPEUTICS INC   |  BIORELIX INC   |  EUTHYMICS BIOSCIENCE INC   |  AKEBIA THERAPEUTICS, INC.   |  AERPIO THERAPEUTICS, INC.   |  NEUROVANCE, INC.   |  EBI LIFE SCIENCES, INC.   |  IMAGINAB, INC.   |  GALERA THERAPEUTICS, INC.   |  BIONANO GENOMICS, INC   |  EUTHYMICS BIOSCIENCE, INC.   |  ICEBREAKER HEALTH, INC.   |  ANNEXON, INC.   |  TSCAN THERAPEUTICS, INC.   |  RENOVACOR, INC.   |  LIGHTHOUSE PHARMACEUTICALS, INC.
DUANE 
 
NASH 
DIRECTOR
VITAL THERAPIES INC   |  AERPIO THERAPEUTICS, INC.   |  IMMUNIC, INC.
STEVE 
 
PAKOLA 
EXECUTIVE OFFICER
AERPIO THERAPEUTICS, INC.
KEVIN 
 
PETERS 
EXECUTIVE OFFICER
AKEBIA THERAPEUTICS, INC.   |  AERPIO THERAPEUTICS, INC.   |  AVID GROUP, INC.
JOHN 
 
RICE 
DIRECTOR
JOHNSONDIVERSEY HOLDINGS INC   |  ALGAL SCIENTIFIC CORP   |  ESSENCE GROUP HOLDINGS CORP   |  AKEBIA THERAPEUTICS, INC.   |  RFG HOLDINGS, LLLP   |  AERPIO THERAPEUTICS, INC.   |  WALKER + DUNLOP, INC.   |  REASON TO BELIEVE, LLC   |  SUSTAIN LLC   |  VIRTUE LABS, LLC   |  ENABLE INJECTIONS, INC   |  AMGI HOLDINGS, INC.   |  SIGMA LABS, INC.   |  PRIME PROPERTY FUND, LLC   |  SURROUND CARE, LLC
MUNEER 
 
SATTER 
DIRECTOR
DEL TACO HOLDINGS, INC.   |  VITAL THERAPIES INC   |  AERPIO THERAPEUTICS, INC.   |  AERPIO PHARMACEUTICALS, INC.   |  ANNEXON, INC.   |  ALZHEON, INC.
ROBERT 
 
SHALWITZ 
EXECUTIVE OFFICER
AKEBIA THERAPEUTICS, INC.   |  AERPIO THERAPEUTICS, INC.   |  INVIRSA, INC.
LAUREN 
 
SILVERMAN 
DIRECTOR
ASCENT THERAPEUTICS INC   |  VIAMET PHARMACEUTICALS INC   |  PULMATRIX INC   |  CEQUENT PHARMACEUTICALS INC   |  RA PHARMACEUTICALS, INC.   |  ANCHORTHERAPEUTICS, INC   |  CELLADON CORP   |  VIAMET PHARMACEUTICALS HOLDINGS LLC   |  AERPIO THERAPEUTICS, INC.   |  PROTEOSTASIS THERAPEUTICS, INC.
PAUL 
 
WEISS 
DIRECTOR
EUTHYMICS BIOSCIENCE INC   |  PIPELINE FINANCE LLC   |  AKEBIA THERAPEUTICS, INC.   |  GINNIE ACCEPTANCE COMPANY, LLC   |  AERPIO THERAPEUTICS, INC.   |  NEUROVANCE, INC.   |  EBI LIFE SCIENCES, INC.   |  TAMIR BIOTECHNOLOGY, INC.   |  WEST HILL STRATEGIC BOND FUND, LP   |  EUTHYMICS BIOSCIENCE, INC.   |  FLUGEN INC   |  INVENRA INC.   |  VENTURE INVESTORS HEALTH FUND 6 LIMITED PARTNERSHIP   |  TEN BAY BIO, INC.   |  VENTURE INVESTORS HEALTH FUND 7 LIMITED PARTNERSHIP
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2016-11-14
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2016-10-31 
2016-04-15
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2016-03-31 
2014-05-06
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-04-22 
2013-11-15
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-08-28 
2013-09-12
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-08-28 
2012-11-16
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-08-28 
2012-01-05
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2011-12-22 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#